Position in NVO
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$747,816
+$119,097 QoQ
Shares Held
15,599
-8.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#596
of 1,348 holders
Holding Since
Jun 2025
3 quarters on record
Voting authority
Sole 70%
Shared 0%
None 30%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026WESTFIELD CAPITAL MANAGEMENT CO LP holds $691,252,397 across 8 Drug Manufacturers - General names. NVO ranks #8 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
416,732 | $499,840,904 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
1,287,629 | $162,679,047 | |
| 3 | JNJ |
Johnson & Johnson
|
35,772 | $9,085,014 | |
| 4 | MRK |
Merck & Co., Inc.
|
53,297 | $6,848,664 | |
| 5 | AMGN |
Amgen Inc
|
17,047 | $6,173,059 | |
| 6 | PFE |
Pfizer Inc
|
162,023 | $3,901,513 | |
| 7 | ABBV |
AbbVie Inc.
|
7,854 | $1,976,380 | |
| 8 | NVO |
Novo Nordisk A S
This page
|
15,599 | $747,816 |
All Filings in NVO
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $747,816 | 15,599 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $628,719 | 17,108 | Shares | Sole | 2026-05-11 | |
| 2025-06-30 | $413,774 | 5,995 | Shares | Sole | 2025-08-12 | |
| No filing history on record for this holder in this stock. | ||||||